BLIS Technologies Ltd Sustainability Reports
Blis Technologies Limited discovers, develops, and commercializes advanced oral probiotics for ear, nose, throat, and dental health. Its products are formulated using specialized bacterial strains like BLIS K12 and BLIS M18.
Sector: Manufacturing
Country: New Zealand
Exchange: New Zealand Exchange (NZX)
FIGI: BBG001SC6414
12 reports from 2015 to 2026
